These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 2661292)

  • 1. [Value of a score using clinical and biological variables for determining the benignity or malignancy of a hepatic mass].
    Menu Y; Vilgrain V; Asselain B; Scherrer A; Sellier N; Thonnart B; Nahum H
    Gastroenterol Clin Biol; 1989 Apr; 13(4):340-2. PubMed ID: 2661292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aid to the clinical and biological diagnosis of malignancy in a nodular hepatic image discovered by echography].
    Asselain B; Gueguen A; Scherrer A; Flahaut A
    Bull Cancer; 1987; 74(1):66-74. PubMed ID: 3552084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal liver disease: neural network-aided diagnosis based on clinical and laboratory data.
    Rudzki K; Hartleb M; Sadowski T; Rudzka J
    Gastroenterol Clin Biol; 1997; 21(2):98-102. PubMed ID: 9161474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multivariate logistic regression analysis in predicting malignancy for patients with ovarian tumors.
    Hata K; Akiba S; Hata T; Miyazaki K
    Gynecol Oncol; 1998 Mar; 68(3):256-62. PubMed ID: 9570977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection Probability Score (IPS): A method to help assess the probability of infection in critically ill patients.
    Peres Bota D; Mélot C; Lopes Ferreira F; Vincent JL
    Crit Care Med; 2003 Nov; 31(11):2579-84. PubMed ID: 14605527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group.
    Timmerman D; Testa AC; Bourne T; Ferrazzi E; Ameye L; Konstantinovic ML; Van Calster B; Collins WP; Vergote I; Van Huffel S; Valentin L;
    J Clin Oncol; 2005 Dec; 23(34):8794-801. PubMed ID: 16314639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ultrasonic studies of the abdominal organs. II. Its diagnostic value in liver diseases].
    Mechkov G; Grigorov N; Karamfilova R
    Vutr Boles; 1982; 21(1):36-45. PubMed ID: 7090356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of ultrasonography in the diagnosis of cirrhosis. Retrospective studies of 100 consecutive tests].
    Seitz JF; Boustière C; Maurin P; Aimino R; Durbec JP; Botta D; Escoffier JM; Gauthier AP
    Gastroenterol Clin Biol; 1983; 7(8-9):734-9. PubMed ID: 6618077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal and neonatal hepatic tumors.
    Isaacs H
    J Pediatr Surg; 2007 Nov; 42(11):1797-803. PubMed ID: 18022426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory pseudotumor of the liver: demographics, diagnosis, and the case for nonoperative management.
    Koea JB; Broadhurst GW; Rodgers MS; McCall JL
    J Am Coll Surg; 2003 Feb; 196(2):226-35. PubMed ID: 12595051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
    Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
    Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Anticancer Res; 1995; 15(6B):2731-7. PubMed ID: 8669855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of ultrasound-guided cyto-biopsy in the study of livers with abnormal ultrasonograms].
    Sautereau D; Vire O; Cazes PY; Cazals JB; Catanzano G; Claude R; Pillegand B
    Ann Gastroenterol Hepatol (Paris); 1988; 24(4):205-8. PubMed ID: 3048202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome.
    Befeler AS; Palmer DE; Hoffman M; Longo W; Solomon H; Di Bisceglie AM
    Arch Surg; 2005 Jul; 140(7):650-4; discussion 655. PubMed ID: 16027329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of survival for patients with bullous pemphigoid: a prospective study.
    Joly P; Benichou J; Lok C; Hellot MF; Saiag P; Tancrede-Bohin E; Sassolas B; Labeille B; Doutre MS; Gorin I; Pauwels C; Chosidow O; Caux F; Estève E; Dutronc Y; Sigal M; Prost C; Maillard H; Guillaume JC; Roujeau JC
    Arch Dermatol; 2005 Jun; 141(6):691-8. PubMed ID: 15967914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of psychiatric disorders in liver transplantation candidates: logistic regression models.
    Rocca P; Cocuzza E; Rasetti R; Rocca G; Zanalda E; Bogetto F
    Liver Transpl; 2003 Jul; 9(7):721-6. PubMed ID: 12827559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
    Teh SH; Sheppard BC; Schwartz J; Orloff SL
    Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.